lopinavir has been researched along with Shock, Septic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fylaki, E; Hassapopoulou-Matamis, H; Mentis, A; Politis, C; Vlachogianni, G | 1 |
1 other study(ies) available for lopinavir and Shock, Septic
Article | Year |
---|---|
A case of COVID-19 Convalescent Plasma Donation in Greece: Directed donation for compassionate use in the donor's critically ill father.
Topics: Adrenal Cortex Hormones; Aged; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Cardiotonic Agents; Combined Modality Therapy; Compassionate Use Trials; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Directed Tissue Donation; Drug Resistance, Multiple; Drug Substitution; Drug Therapy, Combination; Fatal Outcome; Greece; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Male; Respiration, Artificial; Ritonavir; Shock, Septic; Superinfection; Time-to-Treatment | 2020 |